Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,916 | -69,045 | -36,917 | -23,155 | -22,181 |
| Depreciation Amortization | 1,325 | 972 | 892 | 1,169 | 1,114 |
| Accounts receivable | N/A | N/A | N/A | -2,428 | -467 |
| Other Working Capital | -2,099 | -9,646 | 439 | -3,223 | -874 |
| Other Operating Activity | -17,861 | 30,296 | 3,105 | 4,062 | 4,138 |
| Operating Cash Flow | $-37,551 | $-47,423 | $-32,481 | $-23,575 | $-18,270 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,879 | -8,134 | -2,211 | -1,304 | -824 |
| Investing Cash Flow | $-1,879 | $-8,134 | $-2,211 | $-1,304 | $-824 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,889 | 54,026 | N/A | N/A | 717 |
| Common Stock Issued | 130 | 5 | 44,516 | 26,932 | 23,061 |
| Other Financing Activity | -61 | -43 | -500 | -1,414 | -568 |
| Financing Cash Flow | $34,958 | $53,988 | $44,016 | $25,518 | $23,210 |
| Beginning Cash Position | 19,243 | 20,812 | 11,488 | 10,849 | 6,733 |
| End Cash Position | 14,771 | 19,243 | 20,812 | 11,488 | 10,849 |
| Net Cash Flow | $-4,472 | $-1,569 | $9,324 | $639 | $4,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,551 | -47,423 | -32,481 | -23,575 | -18,270 |
| Capital Expenditure | -1,879 | -8,144 | -2,211 | -1,304 | -824 |
| Free Cash Flow | -39,430 | -55,567 | -34,692 | -24,879 | -19,094 |